These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 3917299

  • 1. Acceleration of growth in two children treated with human growth hormone-releasing factor.
    Thorner MO, Reschke J, Chitwood J, Rogol AD, Furlanetto R, Rivier J, Vale W, Blizzard RM.
    N Engl J Med; 1985 Jan 03; 312(1):4-9. PubMed ID: 3917299
    [Abstract] [Full Text] [Related]

  • 2. Acceleration of growth rate in growth hormone-deficient children treated with human growth hormone-releasing hormone.
    Thorner MO, Rogol AD, Blizzard RM, Klingensmith GJ, Najjar J, Misra R, Burr I, Chao G, Martha P, Mcdonald J.
    Pediatr Res; 1988 Aug 03; 24(2):145-51. PubMed ID: 3141891
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone treatment for short stature.
    Van Vliet G, Styne DM, Kaplan SL, Grumbach MM.
    N Engl J Med; 1983 Oct 27; 309(17):1016-22. PubMed ID: 6684729
    [Abstract] [Full Text] [Related]

  • 4. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
    Kastrup KW, Andersen H, Eskildsen PC, Jacobsen BB, Krabbe S, Petersen KE.
    Acta Paediatr Scand Suppl; 1979 Oct 27; 277():8-13. PubMed ID: 396757
    [Abstract] [Full Text] [Related]

  • 5. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency.
    Lustig RH, Schriock EA, Kaplan SL, Grumbach MM.
    Pediatrics; 1985 Aug 27; 76(2):274-9. PubMed ID: 3927254
    [Abstract] [Full Text] [Related]

  • 6. Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency.
    Borges JL, Blizzard RM, Gelato MC, Furlanetto R, Rogol AD, Evans WS, Vance ML, Kaiser DL, MacLeod RM, Merriam GR, Loriaux DL, Spiess J, Rivier J, Vale W, Thorner MO.
    Lancet; 1983 Jul 16; 2(8342):119-24. PubMed ID: 6134978
    [Abstract] [Full Text] [Related]

  • 7. Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients.
    Huseman CA, Colombo JL, Brooks MA, Smay JR, Greger NG, Sammut PH, Bier DM.
    Pediatr Pulmonol; 1996 Aug 16; 22(2):90-5. PubMed ID: 8875581
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation.
    Plotnick LP, Van Meter QL, Kowarski AA.
    Pediatrics; 1983 Mar 16; 71(3):324-7. PubMed ID: 6681897
    [Abstract] [Full Text] [Related]

  • 11. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
    Codner E, Cassorla F, Tiulpakov AN, Mericq MV, Avila A, Pescovitz OH, Svensson J, Cerchio K, Krupa D, Gertz BJ, Murphy G.
    Clin Pharmacol Ther; 2001 Jul 16; 70(1):91-8. PubMed ID: 11452249
    [Abstract] [Full Text] [Related]

  • 12. Acquired refractoriness to growth hormone in a patient with isolated growth hormone deficiency: growth and plasma somatomedin-C response to high-dose growth hormone therapy.
    Winterer J, Chrousos G, Cassorla F, Loriaux DL.
    J Pediatr; 1984 Jun 16; 104(6):908-11. PubMed ID: 6539376
    [No Abstract] [Full Text] [Related]

  • 13. Somatocrinin--growth hormone releasing factor--another hypothalamic hormone for clinical use.
    Romer TE, Rymkiewicz-Kluczyńska B, Szarras-Czapnik M.
    Endokrynol Pol; 1987 Jun 16; 38(1):145-53. PubMed ID: 3123206
    [No Abstract] [Full Text] [Related]

  • 14. Serum levels of somatomedin A and growth during long-term treatment of patients with pituitary dwarfism with human growth hormone.
    Takano K, Hizuka N, Shizume K, Hasumi Y.
    Acta Endocrinol (Copenh); 1979 Nov 16; 92(3):385-97. PubMed ID: 229685
    [Abstract] [Full Text] [Related]

  • 15. Nine months' subcutaneous therapy with synthetic growth hormone releasing factor in children with short stature.
    Hümmelink R, Rohwedder R, Sippell WG.
    Acta Paediatr Scand Suppl; 1987 Nov 16; 331():48-52. PubMed ID: 2886000
    [Abstract] [Full Text] [Related]

  • 16. Clonidine accelerates growth in children with impaired growth hormone secretion.
    Pintor C, Cella SG, Corda R, Locatelli V, Puggioni R, Loche S, Müller EE.
    Lancet; 1985 Jun 29; 1(8444):1482-5. PubMed ID: 2861413
    [Abstract] [Full Text] [Related]

  • 17. Human growth hormone-releasing hormone (hGH-RH; hGRF) treatment of four patients with GH deficiency.
    Takano K, Hizuka N, Asakawa K, Chihara K, Sanayama K, Shizume K.
    Endocrinol Jpn; 1988 Oct 29; 35(5):775-81. PubMed ID: 3146502
    [Abstract] [Full Text] [Related]

  • 18. [Progress in endocrine function tests. Growth hormone-releasing factor test].
    Takano K, Shizume K.
    Nihon Rinsho; 1987 Nov 29; 45(11):2514-24. PubMed ID: 3127614
    [No Abstract] [Full Text] [Related]

  • 19. Abnormal growth hormone and dwarfism.
    Abucham-Filho JZ, Czepielewski MA, Ribeiro SR, Jaber HE, Lengyel AM, Chacra AR, Vieira JG.
    N Engl J Med; 1985 Jul 25; 313(4):268-9. PubMed ID: 4040212
    [No Abstract] [Full Text] [Related]

  • 20. Effects of hGRF treatment of a patient with hGRF deficiency.
    Takano K, Hizuka N, Tanaka I, Shizume K.
    Endocrinol Jpn; 1985 Aug 25; 32(4):511-6. PubMed ID: 3936701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.